Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3358-3359

  Elgalib, A ^c   Perry, M ^c   Aboud, M ^c   Mullen, J ^d   O'Shea, S ^a,d   Chrystie, I L ^d   Kulasegaram, R ^c   Tong, C Y W ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c HIV   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; DIAGNOSTIC TEST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE SEQUENCE; GENOTYPE; GENOTYPIC RESISTANCE TEST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; PHYSICIAN; PRIORITY JOURNAL; SCREENING TEST; TREATMENT FAILURE; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77956813103     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01335-10     Document Type: Article

References (8)

1. Clumeck, N., A. Pozniak, and F. Raffi. 2008. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med. 9:65-71. (Pubitemid 351228129)
2. Gazzard, B. G., J. Anderson, A. Babiker, M. Boffito, G. Brook, G. Brough, D. Churchill, B. Cromarty, S. Das, M. Fisher, A. Freedman, A. M. Geretti, M. Johnson, S. Khoo, C. Leen, D. Nair, B. Peters, A. Phillips, D. Pillay, A. Pozniak, J. Walsh, E. Wilkins, I. Williams, M. Williams, and M. Youle. 2008. British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 9:563-608.
3. Hammer, S. M., J. J. Eron, Jr., P. Reiss, R. T. Schooley, M. A. Thompson, S. Walmsley, P. Cahn, P. M. A. Fischl, J. M. Gatell, M. S. Hirsch, D. M. Jacobsen, J. S. G. Montaner, D. D. Richman, P. G. Yeni, and P. A. Volberding. 2008. Antiretroviral treatment of adult with HIV infection: 2008 recommendations of the International AIDS Society - USA panel. JAMA 300:555-570.
4. Mackie, N. S. Dustan, M. O. McClure, J. N. Weber, and J. R. Clarke. 2004. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia. J. Virol. Methods 119:73-78.
5. Mitsuya, Y., M. A. Winters, W. J. Fessel, S. Y. Rhee, S. Slome, J. Flamm, M. Horberg, L. Hurley, D. Klein, and R. W. Shafer. 2006. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL. J. Acquir. Immune Defic. Syndr. 43:56-59.
6. Tong, C. Y. W., J. Mullen, R. Kulasegaram, A. De Ruiter, S. O'Shea, and I. L. Chrystie. 2005. Genotyping of B and non-B subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 43:4623-4627.
7. Verhofstede, C., F. Van Wanzeele, B. Van Der Gucht, J. Pelgrom, L. Vandekerckhove, J. Plum, and D. Vogelaers. 2007. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/mL. J. Med. Virol. 79:1254-1260.
8. Waters, L., S. Mandalia, and D. Asboe. 2006. Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml. AIDS 20:778-779. (Pubitemid 43884307)